In a comment published alongside the Lancet article, professors Ian Jones and Polly Roy reportedly said: "The development of the Sputnik V vaccine has been criticised for unseemly haste, corner cutting, and an absence of transparency".
Russia's Sputnik V vaccine against novel coronavirus has shown 91.6 per cent efficacy in the phase 3 trial without any serious side effects.
The vaccine had faced skepticism because Russian Federation approved it in August before the phase 3 trials were complete. Partnership between Russian Federation and Mexico will save many lives and protect the population by using one of the best vaccines in the world.
The vaccine's developers on Tuesday published new data, allaying transparency concerns about the jab which Russian Federation rolled out more than a month before.
"The aim is to make sure that we can deliver supplies very quickly, i.e., the day on which the vaccine gets the green light", he told a press conference.
On Wednesday, the banner headline of the pro-Kremlin Izvestia daily's front page celebrated the "successful launch" of the jab.
Sputnik V has the advantage of being relatively cheap and able to be kept at normal refrigerator temperatures rather than far below freezing for some other vaccines. This is the first batch of a total of 2 million doses that are expected to arrive in the coming months.
And there may even be a fourth, with the Anglo-Swedish firm AstraZeneca and the developers of Sputnik V having said they are working to combine their respective vaccines.
They include the former Soviet republics of Belarus, Armenia and Turkmenistan; Latin American nations including Argentina, Bolivia and Venezuela; African nations such as Algeria as well as Serbia, Iran, Palestine and United Arab Emirates. "It is important that the country has its own production independent from Russian Federation or others", said Denis Logunov.
It now joins the list of high-efficacy vaccines, including those developed by Pfizer, Oxford/AstraZeneca, and Moderna.
Russian Federation applied last month for registration of the Sputnik V jab with the European Union through the European Medicines Agency (EMA).
Brazil, India, Kazakhstan and South Korea are now producing the jab, though not all them have made it available to the public yet.
RDIF applied for registration of Sputnik V in the European Union last month and German Chancellor Angela Merkel has expressed willingness to its use once the jab receives the regulatory nod.
The small fragment is a genetic code of the coronavirus and produces the spike protein. The trial was conducted across 25 hospitals and polyclinics in Moscow, Russia. The vaccine is therefore called Sputnik V.
Russian Federation made the vaccine available to the wider public in December, when Europe and the United States were just deploying the first doses of the vaccines made by their pharmaceutical companies.
The West Bank, where 3.1 million Palestinians live, has reported 101, 508 coronavirus cases, with 1,276 deaths. By the end of the year, officials here intend to vaccinate 60 percent of the domestic population.
Peskov dismissed those concerns.
The following two tabs change content below. He has managed and overseen start ups in Mining, Shipping, Technology and Financial Services.
- United and City looking to create El Classico in Manchester
- Biden is right to go big on COVID-19 relief
- Trump names new impeachment team lawyers
- Best ways to make your website stand out from the rest
- Trump Bears 'Unmistakable' Responsibility for Capitol Riot, House Impeachment Brief Argues
- Kremlin critic Alexei Navalny jailed, declares Putin 'the Underwear Poisoner'
- Trump names 2 attorneys to lead impeachment defense
- Clock ticking as Williams returns to Australia looking for 24 Reuters
- Defoe strengthens Euros case
- Can Atleti snatch La Liga's title away from Barca?